| Photosensitizers in antibacterial photodynamic therapy: An overview J Ghorbani, D Rahban, S Aghamiri, A Teymouri, A Bahador Laser therapy 27 (4), 293-302, 2018 | 263 | 2018 |
| Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects AJ Abadi, S Mirzaei, MK Mahabady, F Hashemi, A Zabolian, F Hashemi, ... Phytotherapy Research 36 (1), 189-213, 2022 | 114 | 2022 |
| Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology M Ashrafizadeh, S Aghamiri, SC Tan, A Zarrabi, E Sharifi, N Rabiee, ... Nano Today 45, 101532, 2022 | 55 | 2022 |
| The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: A systematic review and meta-analysis HV Kord, GM Tinsley, HO Santos, H Zand, A Nazary, S Fatahi, Z Mokhtari, ... Clinical nutrition 40 (4), 1811-1821, 2021 | 48 | 2021 |
| Opportunities and challenges of the tag-assisted protein purification techniques: Applications in the pharmaceutical industry MM Gomari, N Saraygord-Afshari, M Farsimadan, N Rostami, S Aghamiri, ... Biotechnology advances 45, 107653, 2020 | 47 | 2020 |
| Nanoparticles-mediated CRISPR/Cas9 delivery: recent advances in cancer treatment S Aghamiri, S Talaei, AA Ghavidel, F Zandsalimi, S Masoumi, ... Journal of Drug Delivery Science and Technology 56, 101533, 2020 | 47 | 2020 |
| Gene regulation by antisense transcription: A focus on neurological and cancer diseases S Najafi, SC Tan, P Raee, Y Rahmati, Y Asemani, EHC Lee, ... Biomedicine & Pharmacotherapy 145, 112265, 2022 | 38 | 2022 |
| Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies S Mirzaei, MDA Paskeh, F Hashemi, A Zabolian, M Hashemi, M Entezari, ... Life Sciences 288, 119948, 2022 | 37 | 2022 |
| Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections S Najafi, SC Tan, S Aghamiri, P Raee, Z Ebrahimi, ZK Jahromi, Y Rahmati, ... Biomedicine & pharmacotherapy 148, 112743, 2022 | 35 | 2022 |
| Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy? S Aghamiri, KF Mehrjardi, S Shabani, M Keshavarz-Fathi, S Kargar, ... Nanomedicine 14 (15), 2083-2100, 2019 | 35 | 2019 |
| Recent insights into the roles of circular RNAs in human brain development and neurologic diseases S Najafi, SMA Zarch, J Majidpoor, S Pordel, S Aghamiri, MF Rasul, ... International Journal of Biological Macromolecules 225, 1038-1048, 2023 | 34 | 2023 |
| Targeting siRNA in colorectal cancer therapy: Nanotechnology comes into view S Aghamiri, A Jafarpour, ZV Malekshahi, M Mahmoudi Gomari, ... Journal of Cellular Physiology 234 (9), 14818-14827, 2019 | 33 | 2019 |
| CiRS-7/CDR1as; An oncogenic circular RNA as a potential cancer biomarker Y Rahmati, Y Asemani, S Aghamiri, F Ezzatifar, S Najafi Pathology-Research and Practice 227, 153639, 2021 | 31 | 2021 |
| Antimicrobial peptides as potential therapeutics for breast cancer S Aghamiri, F Zandsalimi, P Raee, MA Abdollahifar, SC Tan, TY Low, ... Pharmacological Research 171, 105777, 2021 | 28 | 2021 |
| Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy S Aghamiri, S Talaei, S Roshanzamiri, F Zandsalimi, E Fazeli, M Aliyu, ... Expert opinion on drug delivery 17 (6), 753-766, 2020 | 28 | 2020 |
| Cognitive determinants of cervical cancer screening behavior among housewife women in Iran: An application of Health Belief Model SA Towhid Babazadeh, Haidar Nadrian,Hamed Rezakhani Moghaddam, Elaheh Ezzati ... Health Care for Women International 39 (5), 2018 | 28 | 2018 |
| Antimicrobial peptides: a promising strategy for lung cancer drug discovery? F Zandsalimi, S Talaei, M Noormohammad Ahari, S Aghamiri, P Raee, ... Expert Opinion on Drug Discovery 15 (11), 1343-1354, 2020 | 25 | 2020 |
| Small activating RNAs: towards the development of new therapeutic agents and clinical treatments H Ghanbarian, S Aghamiri, M Eftekhary, N Wagner, KD Wagner Cells 10 (3), 591, 2021 | 22 | 2021 |
| Effect of resveratrol on the radiosensitivity of 5‐FU in human breast cancer MCF‐7 cells S Aghamiri, A Jafarpour, F Zandsalimi, M Aghemiri, M Shoja Journal of Cellular Biochemistry 120 (9), 15671-15677, 2019 | 22 | 2019 |
| Overcoming the blood–brain barrier in neurodegenerative disorders and brain tumours Z Ebrahimi, S Talaei, S Aghamiri, NH Goradel, A Jafarpour, B Negahdari IET nanobiotechnology 14 (6), 441-448, 2020 | 19 | 2020 |
